CVS Health

I. , Aug. 17, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS ) today announced the appointment of Teresa Heitsenrether to its Board of Directors and departure of Larry Robbins from its Board. Ms. Heitsenrether joins the CVS Health Board with nearly forty years of financial services leadership experience. She currently serves as Chief Data & Analytics Officer at JPMorgan Chase & Co. and is a member of the firm's Operating Committee. Ms. Heitsenrether will join the Board of Directors effective November 18, 2026. "Teresa's extensive experience leading complex global businesses and driving technology-enabled transformation will be invaluable as CVS Health continues to innovate on its path to become a consumer focused, health technology company," said David Joyner, Chair and Chief Executive Officer of CVS Health.

"We look forward to benefiting from her deep knowledge in data, analytics, artificial intelligence, operational transformation and decades of financial expertise." "I am excited to join the most trusted healthcare company in the country, and look forward to assisting management as they progress to the next phase in the company's strategic journey," said Teresa Heitsenrether. A member of the Board since 2024, Mr. Robbins has served on the Audit and Public Policy and External Affairs Committees. His departure from the Board of Directors was effective on August 13, 2026.

"Larry joined our Board at a pivotal moment in CVS's history and was instrumental in helping sharpen our financial and operational focus during this period of transition for the business. From day one, he has been an invaluable and collaborative member of the Board bringing a focused financial perspective and deep knowledge of the health care industry" said David Joyner, Chair and Chief Executive Officer of CVS Health. "We are grateful for Larry's insights and commitment to help strengthen CVS over the course of these important two years, as we laid our foundation for future success."

"Two years ago we approached CVS Health Board and Management with a proposal to refresh corporate governance, improve operating performance and restore financial flexibility and discipline," said Larry Robbins, CEO of Glenview. "The goal was and has always remained to drive better outcomes for CVS customers, stronger opportunities for CVS associates and the restoration of value for CVS lenders and shareholders. We were honored to partner with the Board in a process of constructive evolution that has led to a cultural renaissance at the Company, significantly improved customer experience, a commitment to technology and innovation, a fully repaired balance sheet, dramatically improved financial performance and the recruitment and elevation of many talented leaders to form the leadership group of a revitalized CVS Health."

About Teresa Heitsenrether Teresa Heitsenrether is Executive Vice President and Chief Data & Analytics Officer of JPMorgan Chase and a member of the firm's Operating Committee.